DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 04 · Volume 15 · October 1989 DOI: 10.1055/s-002-7722

  • 359
    Choay, Jean:

    Structure and Activity of Heparin and Its Fragments: An Overview

  • 365
    Bianchini, P.:

    Therapeutic Potential of Non-Heparin Glycosaminoglycans of Natural Origin

  • 370
    Meuleman, D. G.:

    Synopsis of the Anticoagulant and Antithrombotic Profile of the Low Molecular Weight Heparinoid Org 10172 in Experimental Models

  • 373
    Doutremepuich, Christian; Lalanne, M. C.; Guyot, M.; Doutremepuich, F.; De Sèze, O.; Toulemonde, Francis:

    Laboratory Control of Heparin and Heparin Fragment Treatment: An Experimental Study

  • 378
    Hoppensteadt, Debra; Racanelli, Adrienne; Walenga, Jeanine M.; Fareed, Jawed:

    Comparative Antithrombotic and Hemorrhagic Effects of Dermatan Sulfate, Heparan Sulfate, and Heparin

  • 386
    Racanelli, Adrienne; Hoppensteadt, Debra A.; Fareed, Jawed:

    In Vitro Protamine Neutralization Profiles of Heparins Differing in Source and Molecular Weight

  • 390
    Juhan-Vague, I.; Stassen, J. M.; Alessi, M. C.; Elias, A.; Aillaud, M. F.; Serradimigni, A.; Collen, Desiree:

    Potentiation by Heparin Fragment CY 222 (CHOAY) of Thrombolysis Induced by Human Tissue-Type Plasminogen Activator

  • 395
    Toulemonde, Francis:

    Strategy for the Development of the Low Molecular Weight Heparin Fraction CY 216 in the Prevention of Postoperative Deep Vein Thromboses in General Surgery

  • 401
    Breddin, H. Klaus:

    Low Molecular Weight Heparins and Bleeding

  • 405
    Messmore, Harry L.:

    Clinical Potential of Low Molecular Weight Heparins

  • 409
    Biegholdt, M.; for the European Fraxiparin Study Group:

    Descriptive Analysis of the European Fraxiparin Study

  • 414
    Harenberg, J.; Stehle, G.; Augustin, J.; Zimmermann, R.:

    Comparative Human Pharmacology of Low Molecular Weight Heparins

  • 424
    Haas, Sylvia; Blümel, Gerhard:

    An Objective Evaluation of the Clinical Potential of Low Molecular Weight Heparins in the Prevention of Thromboembolism

  • 435
    Faivre, Rene; Neuhart, Eric; Mirshahi, Massoud; Mirshahi, Mannoucher; Soria, Claudine; Soria, Jeannette; Bassand, Jean Pierre; Caen, Jacques P.; Maurat, Jean Pierre:

    Fibrinolytic and Thrombolytic Parameters in Patients with Deep Vein Thrombosis Treated by Low Molecular Weight and Standard Heparin

  • 440
    Fareed, Jawed; Walenga, Jeanine M.; Hoppensteadt, Debra; Racanelli, Adrienne; Coyne, Erwin:

    Chemical and Biological Heterogeneity in Low Molecular Weight Heparins: Implications for Clinical Use and Standardization

  • 464
    Milazzotto, F.; Carelli, M.; Citone, C.; Marcotullio, G. Di; Giampaolo, P.; Malinconico, U.; Polizzi, C.; Tubaro, M.; Giovannini, E.; Boccardi, L.; Minardi, G.; Biffani, G.; Rubertis, C. De; Nazzari, M.; Cornelli, U.:

    Use of Defibrotide in the Treatment of Acute Myocardial Infarction

  • 470
    Mattioli, G.; Cappello, C.; Fusaro, M. T.:

    Treatment of Acute Myocardial Infarction with Defibrotide

  • 474
    Niada, R.; Porta, R.; Pescador, Rodoeto; Mantovani, M.; Prino, G.:

    Thrombolytic Activity of Defibrotide Against Old Venous Thrombi

  • 480
    Murano, Genesio; Wenzel, Ernst:

    Scholarly Potpourri